Results 1 to 5 of 5
Page 1 of 1
TypeTitleAuthor(s)YearViews
Implications of the use of eukaryotic translation initiation factor 5A (eIF5A) for prognosis and treatment of hepatocellular carcinomaShek, HP; Fatima, S; Lee, NPY201254
 
Tumorigenic properties of serine peptidase inhibitor, Kazal type 1 (SPINK1) in hepatocellular carcinoma (Abstract)Shek, HP; Lee, NPY201147
 
Targeting serine peptidase inhibitor, Kazal type 1 (SPINK1) as a potential treatment for hepatocellular carcinoma (Abstract)Shek, HP; Luk, JMC; Lee, NPY201170
 
Tumorigenic properties of serine peptidase inhibitor, Kazal type 1 (SPINK1) in hepatocellular carcinoma (Poster & Abstract)Shek, HP; Lee, NPY201136
 
The role of serine peptidase inhibitor, Kazal type I (SPINK1) in hepatocellular carcinoma (Poster Presentation)Shek, HP; Luk, JMC; Kwong, A; Lee, NPY201074
 
Page 1 of 1
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download